- Home
- VXRT vs AMTX Comparison
VXRT vs AMTX Comparison
Compare VXRT & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- AMTX
- Stock Information
- Founded
- VXRT N/A
- AMTX 2005
- Country
- VXRT United States
- AMTX United States
- Employees
- VXRT N/A
- AMTX N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- AMTX Major Chemicals
- Sector
- VXRT Health Care
- AMTX Industrials
- Exchange
- VXRT Nasdaq
- AMTX Nasdaq
- Market Cap
- VXRT 119.0M
- AMTX 90.3M
- IPO Year
- VXRT N/A
- AMTX N/A
- Fundamental
- Price
- VXRT $0.43
- AMTX $1.71
- Analyst Decision
- VXRT Strong Buy
- AMTX Strong Buy
- Analyst Count
- VXRT 2
- AMTX 4
- Target Price
- VXRT $3.00
- AMTX $13.18
- AVG Volume (30 Days)
- VXRT 1.8M
- AMTX 1.1M
- Earning Date
- VXRT 05-13-2025
- AMTX 05-08-2025
- Dividend Yield
- VXRT N/A
- AMTX N/A
- EPS Growth
- VXRT N/A
- AMTX N/A
- EPS
- VXRT N/A
- AMTX N/A
- Revenue
- VXRT $47,395,000.00
- AMTX $237,892,000.00
- Revenue This Year
- VXRT N/A
- AMTX $31.76
- Revenue Next Year
- VXRT N/A
- AMTX $86.51
- P/E Ratio
- VXRT N/A
- AMTX N/A
- Revenue Growth
- VXRT 433.43
- AMTX N/A
- 52 Week Low
- VXRT $0.29
- AMTX $1.22
- 52 Week High
- VXRT $1.07
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- VXRT 48.78
- AMTX 57.34
- Support Level
- VXRT $0.44
- AMTX $1.64
- Resistance Level
- VXRT $0.48
- AMTX $1.80
- Average True Range (ATR)
- VXRT 0.04
- AMTX 0.11
- MACD
- VXRT -0.00
- AMTX 0.02
- Stochastic Oscillator
- VXRT 37.12
- AMTX 73.35
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.